| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6d40e044398947e5899630aa24f6402 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate |
2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9612495d779246cc4f19ef42fff18c95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f6d20671831fad3e66fb646fdbd949
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6afd244fadcfde3d9f003b74d77a2f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dac99185f973ae20972c2ff33036b9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62a4c8b4ad4a19ff234082f0d2ae507a |
| publicationDate |
2021-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021013067-A1 |
| titleOfInvention |
Chimeric human papillomavirus type 6 l1 protein |
| abstract |
Provided are a chimeric human papillomavirus type 6 L1 protein and a polynucleotide encoding same. Also provided are an HPV type 6 virus-like particle and a preparation method therefor. The chimeric human papillomavirus type 6 L1 protein comprises an N-terminal fragment derived from an HPV type 6 L1 protein, the N-terminal fragment retaining the immunogenicity of the HPV type 6 L1 protein; and a C-terminal fragment derived from an L1 protein of a second type of papillomavirus having better expression and solubility characteristics compared to L1 proteins of other types of papillomavirus. The chimeric HPV type 6 L1 protein has the immunogenicity of the HPV type 6 L1 protein. The chimeric human papillomavirus type 6 L1 protein has a high expression level and high solubility and can be used in large-scale production of a vaccine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022152204-A1 |
| priorityDate |
2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |